Form 4: Rocket Pharmaceuticals CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 9,650 shares of common stock on August 16, 2024, to cover tax withholding obligations related to vesting RSUs.
Summary
- On August 16, 2024, Gaurav Shah, the CEO of Rocket Pharmaceuticals, sold 9,650 shares of the company's common stock.
- The sale was executed at a price of $18.504 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Shah directly owns 718,419 shares.
- Shah's spouse indirectly owns 207,897 shares.
- The Gaurav D. Shah Irrevocable Trust indirectly owns 198,341 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, with no indication of a change in the executive's confidence in the company.
Industry Context
Sales of shares by company executives are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook for the company, but it's a transaction investors often monitor.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of the stock sale transaction. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.